Provided by Tiger Trade Technology Pte. Ltd.

Lucid Group Inc

5.35
+0.26005.11%
Volume:5.38M
Turnover:27.96M
Market Cap:2.11B
PE:-0.39
High:5.37
Open:5.13
Low:5.01
Close:5.09
52wk High:25.23
52wk Low:2.37
Shares:394.07M
Float Shares:176.00M
Volume Ratio:0.63
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.6500
EPS(LYR):-11.8124
ROE:-125.99%
ROA:-30.23%
PB:-1.99
PE(LYR):-0.45

Loading ...

Option traders moderately bearish in Lucid Group with shares down 0.56%

TIPRANKS
·
Aug 18

AirJoule Technologies price target raised to $10 from $7 at Lucid Capital

TIPRANKS
·
Aug 17

Lucid Diagnostics Price Target Maintained with a $2.50/Share by BTIG

Dow Jones
·
Aug 17

Lucid Diagnostics (LUCD) Receives a Buy from Maxim Group

TIPRANKS
·
Aug 14

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Dow Jones
·
Aug 14

Lucid Group Unveils Gravity GT-S Electric SUV Starting at $125,900

MT Newswires Live
·
Aug 14

Introducing Lucid Gravity GT-S: a New Expression of Performance, Luxury and Versatility

THOMSON REUTERS
·
Aug 14

Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision

TIPRANKS
·
Aug 13

Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 13

Lucid Diagnostics Q2 Adj. EPS $(0.08) Misses $(0.07) Estimate, Sales $1.474M Miss $1.943M Estimate

Benzinga Earnings
·
Aug 13

Lucid Group Registers Preferred and Class A Shares

TIPRANKS
·
Aug 13

Lucid Files Resale Prospectus for up to 75.7 Million Class a Shares, Preferred Stock Conversion Shares

Reuters
·
Aug 13

Lucid Files Resale Prospectus Supplement

THOMSON REUTERS
·
Aug 13

Lucid Group: Resale Prospectus for up to 51.7 Mln Class a Common Stock That May be Issued upon Conversion of Series C Convertible Preferred Stock

THOMSON REUTERS
·
Aug 13

Why Lucid Group (LCID) Is Down 13.9% After Revenue Rose But Losses Deepened Sharply

Simply Wall St.
·
Aug 13

Charged: Lucid reports earnings, reaffirms liquidity runway

TIPRANKS
·
Aug 11

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial

TIPRANKS
·
Aug 11

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Lucid Group Earnings Call Highlights Turnaround Strain

TIPRANKS
·
Aug 09

Lucid Files Form 3 Initial Beneficial Ownership Statement for CFO Alexander De Bock

Reuters
·
Aug 08